MOS
MDCO

MGO One Seven’s Medicines Co MDCO Stock Holding History

MGO One Seven’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12
Closed – – 1902
2018
Q4 		$0 Buy
+12
New +$279 ﹤0.01% 1985

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

MGO One Seven's MDCO Position: Q1 2019 in Review

MGO One Seven sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 12 shares.

MGO One Seven first reported a position in MDCO in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

  • MGO One Seven reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
  • MGO One Seven sold 12 Medicines Co shares in Q1 2019.
  • MGO One Seven first reported a position in Medicines Co in Q4 2018 and held it in 1 quarter.
  • MGO One Seven's Medicines Co position peaked at $0 in Q4 2018.
  • 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.